Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
PLoS One
    January 2025
  1. LANGE M, Koliousis A, Fayez F, Gogarty E, et al
    Schizophrenia more employable than depression? Language-based artificial intelligence model ratings for employability of psychiatric diagnoses and somatic and healthy controls.
    PLoS One. 2025;20:e0315768.
    >> Share

  2. KHAN M, Batool R, Mushtaq U, Iqbal S, et al
    MESS to live with schizophrenic parental history: A systematic review of developmental checkpoints.
    PLoS One. 2025;20:e0313531.
    >> Share

  3. HAZAN H, Funaro MC, Srihari VH
    Measurement properties of instruments to assess insight in psychosis: A systematic review protocol.
    PLoS One. 2025;20:e0316447.
    >> Share

  4. ZHAO R, Shi H, Wang Y, Jiang T, et al
    Allele-specific methylation of SSTR4 associated with aging and cognitive functions in patients with schizophrenia.
    PLoS One. 2025;20:e0303038.
    >> Share

  5. HAZAN H, Tayfur SN, Zhou B, Li F, et al
    The impact of Duration of Untreated Psychosis on functioning and quality of life over one year of Coordinated Specialty Care (CSC).
    PLoS One. 2025;20:e0312740.
    >> Share

  6. PARK SI, Kim S, Park K, Yu U, et al
    Predictors of clozapine concentration and psychiatric symptoms in patients with schizophrenia.
    PLoS One. 2025;20:e0319037.
    >> Share

  7. LEE SC, Chiu EC
    Reliability of the Test of Visual Perceptual Skills-4th Edition for people with schizophrenia.
    PLoS One. 2025;20:e0318148.
    >> Share

  8. MLAY JP, Naidu T, Ramlall S, Patankar K, et al
    Strategies for relapse prevention among people with schizophrenia in KwaZulu-Natal Province, South Africa: Healthcare providers' perspectives.
    PLoS One. 2025;20:e0316313.
    >> Share

  9. JAMEIE M, Bordbar S, Samiee R, Amanollahi M, et al
    Monocytic TLR4 expression and activation in schizophrenia: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0319171.
    >> Share

  10. BEYENE MG, Teferra S, Fenta TG
    Non-adherence and predictors in patients with schizophrenia on second generation antipsychotics at Amanuel Mental Specialized Hospital, Ethiopia.
    PLoS One. 2025;20:e0314403.
    >> Share

  11. RESHID Z, Haile K, Ayano G, Kebede A, et al
    Assessment of treatment outcomes and associated factors among patients treated with clozapine at amanuel mental specialized hospital, Addis Ababa, Ethiopia.
    PLoS One. 2025;20:e0321536.
    >> Share

  12. TAO F, Deng S, Zhuo B, Liu J, et al
    Causal relationship between schizophrenia and five types of dementia: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2025;20:e0322752.
    >> Share

  13. AHMADZADEH K, Sarabi-Jamab A, Beiranvand F, Forouzandeh M, et al
    Moral decision-making is altered in patients with schizophrenia.
    PLoS One. 2025;20:e0322614.
    >> Share

  14. NGONGI LI, Akiba CF, Kilonzo MN, Minja AA, et al
    Barriers, facilitators and potential solutions to implementing Kiddie Schedule for Affective Disorder and Schizophrenia (KSADS) screening tool at Muhimbili National Hospital in Dar es Salaam, Tanzania.
    PLoS One. 2025;20:e0323502.
    >> Share

  15. HONG Y, Chen Y, Bai Y, Tan W, et al
    Cognitive-behavioral therapy for the improvement of negative symptoms and functioning in schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0324685.
    >> Share

  16. HOU PH, Chang GR, Chao YT, Chang YT, et al
    Aripiprazole use and lowering the risk of breast cancer in patient with schizophrenia in a national cohort study.
    PLoS One. 2025;20:e0324257.
    >> Share

  17. FEKIH-ROMDHANE F, Saguem BN, Stambouli M, Hallit S, et al
    Violence victimization and perpetration within the caregiver-patient relationship in schizophrenia: A cross-sectional study in Tunisia.
    PLoS One. 2025;20:e0323312.
    >> Share

  18. GEENJAAR E, Kim D, Calhoun V
    Providing context: Extracting non-linear and dynamic temporal motifs from brain activity.
    PLoS One. 2025;20:e0324066.
    >> Share

    January 2024
  19. PEREZ-ROMERO N, Campos-Jara C, Pesce C, Araya Sierralta S, et al
    Effects of physical exercise on executive functions of individuals with schizophrenia spectrum disorders: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0296273.
    >> Share

  20. CLEMMENSEN L, Lund CN, Andresen BS, Midtgaard J, et al
    Study protocol for RUFUS-A randomized mixed methods pilot clinical trial investigating the relevance and feasibility of rumination-focused cognitive behavioral therapy in the treatment of patients with emergent psychosis spectrum disorders.
    PLoS One. 2024;19:e0297118.
    >> Share

  21. JAKA S, Singh S, Vashist S, Pokhrel S, et al
    Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
    PLoS One. 2024;19:e0296870.
    >> Share

  22. ROSADO D, Intriago B, Loor E, Alcivar F, et al
    Associations between Toxoplasma gondii seropositivity and psychopathological manifestations in schizophrenic patients: A single-center study from Ecuador.
    PLoS One. 2024;19:e0297523.
    >> Share

  23. FEIJS HME, van Aken L, van der Veld WM, van der Heijden PT, et al
    No relations between executive functions and dimensional models of psychopathology or is time the missing link?
    PLoS One. 2024;19:e0288386.
    >> Share


  24. Expression of Concern: Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location.
    PLoS One. 2024;19:e0301152.
    >> Share

  25. LIU J, Sun SJ, Lu Y, Ping X, et al
    Taste dysfunction as a predictor of depression in schizophrenia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0300935.
    >> Share

  26. BASU A, Dutta AK, Bagepally BS, Das S, et al
    Pharmacogenomics-assisted schizophrenia management: A hybrid type 2 effectiveness-implementation study protocol to compare the clinical utility, cost-effectiveness, and barriers.
    PLoS One. 2024;19:e0300511.
    >> Share

  27. MUSLIH M, Chung MH
    Structural validity of the Rosenberg self-esteem scale in patients with schizophrenia in Indonesia.
    PLoS One. 2024;19:e0300184.
    >> Share

  28. HANLON C, Roberts T, Misganaw E, Malla A, et al
    Studying the context of psychoses to improve outcomes in Ethiopia (SCOPE): Protocol paper.
    PLoS One. 2024;19:e0293232.
    >> Share


  29. Correction: Integrated bioinformatics and statistical approach to identify the common molecular mechanisms of obesity that are linked to the development of two psychiatric disorders: Schizophrenia and major depressive disorder.
    PLoS One. 2024;19:e0304339.
    >> Share

  30. HASSANZADEH R, Abrol A, Pearlson G, Turner JA, et al
    A confounder controlled machine learning approach: Group analysis and classification of schizophrenia and Alzheimer's disease using resting-state functional network connectivity.
    PLoS One. 2024;19:e0293053.
    >> Share

  31. RAHMAN A, Russell M, Zheng W, Eckrich D, et al
    SARS-CoV-2 infection is associated with an increase in new diagnoses of schizophrenia spectrum and psychotic disorder: A study using the US national COVID cohort collaborative (N3C).
    PLoS One. 2024;19:e0295891.
    >> Share

  32. EGGER JR, Kaaya S, Swai P, Lawala P, et al
    Functioning and quality of life among treatment-engaged adults with psychotic disorders in urban Tanzania: Baseline results from the KUPAA clinical trial.
    PLoS One. 2024;19:e0304367.
    >> Share

  33. FASSLER L, Bighelli I, Leucht S, Sabe M, et al
    Targeted psychological and psychosocial interventions for auditory hallucinations in persons with psychotic disorders: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0306324.
    >> Share

  34. WANG Y, Bi S, Li X, Zhong Y, et al
    Perturbations in gut microbiota composition in schizophrenia.
    PLoS One. 2024;19:e0306582.
    >> Share

  35. KOLIND ME, Kruse R, Petersen AS, Larsen CS, et al
    Investigating the role of obesity, circadian disturbances and lifestyle factors in people with schizophrenia and bipolar disorder: Study protocol for the SOMBER trial.
    PLoS One. 2024;19:e0306408.
    >> Share

  36. MATHIS WS, Ferrara M, Cahill J, Karmani S, et al
    TimelinePTC: Development of a unified interface for pathways to care collection, visualization, and collaboration in first episode psychosis.
    PLoS One. 2024;19:e0302116.
    >> Share

  37. HUSAIN MO, Hawke LD, Lu Y, Kozloff N, et al
    A mixed-methods study to evaluate the feasibility and preliminary efficacy of delivering the optimal health program (OHP) for youth at clinical high risk (CHR) for psychosis: A study protocol.
    PLoS One. 2024;19:e0306968.
    >> Share

  38. FITZGERALD I, Sahm LJ, Howe J, Maidment I, et al
    Shared decision-making interventions in the choice of antipsychotic prescription in people living with psychosis (SHAPE): Protocol for a realist review.
    PLoS One. 2024;19:e0304626.
    >> Share

  39. REQUENA SS, Loch AA, Mendes KN, Reavley NJ, et al
    Development of mental health first aid guidelines for psychosis for Brazil: A Delphi expert consensus study.
    PLoS One. 2024;19:e0307064.
    >> Share

  40. OSTERGAARD FG, Penninx BWJH, Das N, Arango C, et al
    The aperiodic exponent of neural activity varies with vigilance state in mice and men.
    PLoS One. 2024;19:e0301406.
    >> Share

  41. MIEDLICH SU, Sahay P, Olivares TE, Lamberti JS, et al
    Lifestyle and mood correlates of cardiometabolic risk in people with serious mental illness on second-generation antipsychotic medications.
    PLoS One. 2024;19:e0306798.
    >> Share

  42. MUSLIH M, Chung MH
    Correction: Structural validity of the Rosenberg self-esteem scale in patients with schizophrenia in Indonesia.
    PLoS One. 2024;19:e0308836.
    >> Share

  43. HALLAJIAN AH, Sharifi K, Rostami R, Saeed F, et al
    Neurocognitive effects of 3 mA prefrontal electrical stimulation in schizophrenia: A randomized sham-controlled tDCS-fMRI study protocol.
    PLoS One. 2024;19:e0306422.
    >> Share

  44. BOSWORTH ML, Isles AR, Wilkinson LS, Humby T, et al
    Sex-dependent effects of Setd1a haploinsufficiency on development and adult behaviour.
    PLoS One. 2024;19:e0298717.
    >> Share

  45. LIM MJH, Iyyalol R, Lee JWY, Martin-Iverson MT, et al
    Multi-modal and bi-directional effects of a synthetic Delta9-Tetrahydrocannabinol (THC) analogue, Nabilone, on spatio-temporal binding windows: Evidence from the projected hand illusion.
    PLoS One. 2024;19:e0309614.
    >> Share

  46. PU J, Wang B, Wang Y
    Validity of handgrip strength for assessing cognition and psychotic symptoms in hospitalized patients with stable schizophrenia.
    PLoS One. 2024;19:e0308133.
    >> Share

  47. TYAS TH, Good MD, Pratikno B, Subandi MA, et al
    Unlocking the mentally ill in Indonesia: An empirical study of the effectiveness of a "Bebas Pasung" program in Central Java.
    PLoS One. 2024;19:e0302190.
    >> Share

  48. WANG B, Zhou Y, Yu H, Jiang T, et al
    Correlations between nutritional indicators and cognitive function in patients with stable schizophrenia in a hospital setting.
    PLoS One. 2024;19:e0312227.
    >> Share

  49. ROOSENSCHOON BJ, Deen ML, van Weeghel J, Kamperman AM, et al
    Illness (self) management, clinical and functional recovery as determinants of personal recovery in people with severe mental illnesses: A mediation analysis.
    PLoS One. 2024;19:e0313202.
    >> Share

  50. SAMSON C, Livet A, Gilker A, Potvin S, et al
    Reasoning and interpretation cognitive biases related to psychotic characteristics: An umbrella-review.
    PLoS One. 2024;19:e0314965.
    >> Share

  51. LEE CY, Ahmed N, Ikhtabi S, Duffett P, et al
    The experience of loneliness among people with psychosis: Qualitative meta-synthesis.
    PLoS One. 2024;19:e0315763.
    >> Share

    January 2023
  52. CHAVES MF, Rodrigues C, Ribeiro S, Mota NB, et al
    Grammatical impairment in schizophrenia: An exploratory study of the pronominal and sentential domains.
    PLoS One. 2023;18:e0291446.
    >> Share

  53. AGARWAL SM, Dissanayake J, Agid O, Bowie C, et al
    Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
    PLoS One. 2023;18:e0288354.
    >> Share

  54. MARTZOUKOU M, Papadopoulos D, Kosmidis MH
    Syntactic and affective prosody recognition: Schizophrenia vs. Autism spectrum disorders.
    PLoS One. 2023;18:e0292325.
    >> Share

  55. JUCHNOWICZ D, Dzikowski M, Rog J, Waszkiewicz N, et al
    The usefulness of a complete blood count in the prediction of the first episode of schizophrenia diagnosis and its relationship with oxidative stress.
    PLoS One. 2023;18:e0292756.
    >> Share

  56. LYLES S, Khan Z, Qureshi O, Shaikh M, et al
    A systematic review of the effectiveness and implementation readiness of psychosocial interventions for psychosis in South Asia.
    PLoS One. 2023;18:e0283411.
    >> Share

  57. CLEMENTI L, Arnone E, Santambrogio MD, Franceschetti S, et al
    Anatomically compliant modes of variations: New tools for brain connectivity.
    PLoS One. 2023;18:e0292450.
    >> Share

  58. ABDIN E, Seet V, Jeyagurunathan A, Tan SC, et al
    Validation of the 12-item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore.
    PLoS One. 2023;18:e0294908.
    >> Share

  59. LAWRIE S, Hanlon C, Manda-Taylor L, Knapp M, et al
    Psychosis Recovery Orientation in Malawi by Improving Services and Engagement (PROMISE) protocol.
    PLoS One. 2023;18:e0293370.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016